Previous Article | Next Article 
Molecular and Cellular Biology, June 2004, p. 4994-5004, Vol. 24, No. 11
0270-7306/04/$08.00+0 DOI: 10.1128/MCB.24.11.4994-5004.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
The Nuclear Hormone Receptor Coactivator NRC Is a Pleiotropic Modulator Affecting Growth, Development, Apoptosis, Reproduction, and Wound Repair
Muktar A. Mahajan,1 Sharmistha Das,1 Hong Zhu,1 Marjana Tomic-Canic,2 and Herbert H. Samuels1*
Departments of Pharmacology and Medicine,1
Departments of Dermatology and Microbiology, New York University School of Medicine, New York, New York 100162
Received 7 January 2004/
Returned for modification 4 February 2004/
Accepted 18 March 2004
Nuclear hormone receptor coregulator (NRC) is a 2,063-amino-acid coregulator of nuclear hormone receptors and other transcription factors (e.g., c-Fos, c-Jun, and NF-
B). We and others have generated C57BL/6-129S6 hybrid (C57/129) NRC+/ mice that appear outwardly normal and grow and reproduce. In contrast, homozygous deletion of the NRC gene is embryonic lethal. NRC/ embryos are always smaller than NRC+/+ embryos, and NRC/ embryos die between 8.5 and 12.5 days postcoitus (dpc), suggesting that NRC has a pleotrophic effect on growth. To study this, we derived mouse embryonic fibroblasts (MEFs) from 12.5-dpc embryos, which revealed that NRC/ MEFs exhibit a high rate of apoptosis. Furthermore, a small interfering RNA that targets mouse NRC leads to enhanced apoptosis of wild-type MEFs. The finding that C57/129 NRC+/ mice exhibit no apparent phenotype prompted us to develop 129S6 NRC+/ mice, since the phenotype(s) of certain gene deletions may be strain dependent. In contrast with C57/129 NRC+/ females, 20% of 129S6 NRC+/ females are infertile while 80% are hypofertile. The 129S6 NRC+/ males produce offspring when crossed with wild-type 129S6 females, although fertility is reduced. The 129S6 NRC+/ mice tend to be stunted in their growth compared with their wild-type littermates and exhibit increased postnatal mortality. Lastly, both C57/129 NRC+/ and 129S6 NRC+/ mice exhibit a spontaneous wound healing defect, indicating that NRC plays an important role in that process. Our findings reveal that NRC is a coregulator that controls many cellular and physiologic processes ranging from growth and development to reproduction and wound repair.
* Corresponding author. Mailing address: Departments of Pharmacology and Medicine, New York University School of Medicine, 550 First Ave., New York, NY 10016. Phone: (212) 263-6279. Fax: (212) 263-7133. E-mail:
herbert.samuels{at}med.nyu.edu.
Molecular and Cellular Biology, June 2004, p. 4994-5004, Vol. 24, No. 11
0022-538X/04/$08.00+0 DOI: 10.1128/MCB.24.11.4994-5004.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Kim, D.-H., Lee, J., Lee, B., Lee, J. W.
(2009). ASCOM Controls Farnesoid X Receptor Transactivation through Its Associated Histone H3 Lysine 4 Methyltransferase Activity. Mol. Endocrinol.
23: 1556-1562
[Abstract]
[Full Text]
-
Lee, J., Kim, D.-H., Lee, S., Yang, Q.-H., Lee, D. K., Lee, S.-K., Roeder, R. G., Lee, J. W.
(2009). A tumor suppressive coactivator complex of p53 containing ASC-2 and histone H3-lysine-4 methyltransferase MLL3 or its paralogue MLL4. Proc. Natl. Acad. Sci. USA
106: 8513-8518
[Abstract]
[Full Text]
-
Garapaty, S., Xu, C.-F., Trojer, P., Mahajan, M. A., Neubert, T. A., Samuels, H. H.
(2009). Identification and Characterization of a Novel Nuclear Protein Complex Involved in Nuclear Hormone Receptor-mediated Gene Regulation. J. Biol. Chem.
284: 7542-7552
[Abstract]
[Full Text]
-
Lee, J., Saha, P. K., Yang, Q.-H., Lee, S., Park, J. Y., Suh, Y., Lee, S.-K., Chan, L., Roeder, R. G., Lee, J. W.
(2008). Targeted inactivation of MLL3 histone H3-Lys-4 methyltransferase activity in the mouse reveals vital roles for MLL3 in adipogenesis. Proc. Natl. Acad. Sci. USA
105: 19229-19234
[Abstract]
[Full Text]
-
Antonson, P., Jakobsson, T., Almlof, T., Guldevall, K., Steffensen, K. R., Gustafsson, J.-A.
(2008). RAP250 Is a Coactivator in the Transforming Growth Factor {beta} Signaling Pathway That Interacts with Smad2 and Smad3. J. Biol. Chem.
283: 8995-9001
[Abstract]
[Full Text]
-
Li, Q., Chu, M.-J., Xu, J.
(2007). Tissue- and Nuclear Receptor-Specific Function of the C-Terminal LXXLL Motif of Coactivator NCoA6/AIB3 in Mice. Mol. Cell. Biol.
27: 8073-8086
[Abstract]
[Full Text]
-
Mahajan, M. A., Murray, A., Levy, D., Samuels, H. H.
(2007). Nuclear Receptor Coregulator (NRC): Mapping of the Dimerization Domain, Activation of p53 and STAT-2, and Identification of the Activation Domain AD2 Necessary for Nuclear Receptor Signaling. Mol. Endocrinol.
21: 1822-1834
[Abstract]
[Full Text]
-
Lee, S., Lee, D.-K., Dou, Y., Lee, J., Lee, B., Kwak, E., Kong, Y.-Y., Lee, S.-K., Roeder, R. G., Lee, J. W.
(2006). Coactivator as a target gene specificity determinant for histone H3 lysine 4 methyltransferases. Proc. Natl. Acad. Sci. USA
103: 15392-15397
[Abstract]
[Full Text]
-
Tian, H., Mahajan, M. A., Wong, C. T., Habeos, I., Samuels, H. H.
(2006). The N-Terminal A/B Domain of the Thyroid Hormone Receptor-{beta}2 Isoform Influences Ligand-Dependent Recruitment of Coactivators to the Ligand-Binding Domain. Mol. Endocrinol.
20: 2036-2051
[Abstract]
[Full Text]
-
Yeom, S.-Y., Kim, G. H., Kim, C. H., Jung, H. D., Kim, S.-Y., Park, J.-Y., Pak, Y. K., Rhee, D.-K., Kuang, S.-Q., Xu, J., Han, D. J., Song, D.-K., Lee, J. W., Lee, K.-U., Kim, S.-W.
(2006). Regulation of Insulin Secretion and {beta}-Cell Mass by Activating Signal Cointegrator 2. Mol. Cell. Biol.
26: 4553-4563
[Abstract]
[Full Text]
-
Choi, E., Lee, S., Yeom, S.-Y., Kim, G. H., Lee, J. W., Kim, S.-W.
(2005). Characterization of Activating Signal Cointegrator-2 as a Novel Transcriptional Coactivator of the Xenobiotic Nuclear Receptor Constitutive Androstane Receptor. Mol. Endocrinol.
19: 1711-1719
[Abstract]
[Full Text]
-
Mahajan, M. A., Samuels, H. H.
(2005). Nuclear Hormone Receptor Coregulator: Role in Hormone Action, Metabolism, Growth, and Development. Endocr. Rev.
26: 583-597
[Abstract]
[Full Text]